Drug comparisons
Insulin Aspart Human vs Ertugliflozin
Insulin Aspart is injectable insulin for diabetes, while Ertugliflozin is oral SGLT2 inhibitor. Insulin Aspart mimics insulin to lower blood sugar, while Ertugliflozin promotes urine glucose excretion.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes comparing injectable insulin therapy to oral SGLT2 inhibitors for blood sugar control.
Bottom line
Both Insulin Aspart and Ertugliflozin are effective antidiabetic medications for managing blood sugar but serve different purposes.
All medication comparisons